HE’D LOVED ME SINCE I WAS EIGHTEEN—THEN HE LOOKED AT ME AND ASKED, “GREER, WHAT DO YOU WANT MOST?”

Greer spent the night verifying the toxicity files.

The timestamps matched the animal facility. Tissue images contained valid instrument signatures. Three subjects developed rapid liver failure after receiving concentrated Aurelia compound.

Nolan had concealed the deaths for seven weeks.

When Greer confronted him, he did not deny the files. He disputed their meaning.

“The doses were fifty times therapeutic,” he said. “They tell us nothing about clinical use.”

“They tell us the compound can kill.”

“Everything can kill at the wrong dose.”

“You hid them from the principal investigator.”

Nolan’s voice hardened. “Because you panic whenever the work becomes morally complicated. You would have shut us down before we understood the mechanism.”

He sounded less like a scientist defending judgment than a man defending ownership.

Greer reported the data to regulators and the university ethics office. The decision froze the project entirely. Eighteen months of work became evidence under review.

Nolan stared at her as the submission completed. “You just destroyed the only chance to save it.”

“If the work survives only by hiding deaths, it should not survive.”

The sentence cost her more than she allowed him to see.

The Aurelia compound had shown promise against a rare childhood blood disorder that killed Greer’s younger sister. Greer had spent years telling herself the lab was not grief—it was disciplined purpose. Now she recognized how badly she wanted the result to justify every absence.

Anna died at twelve after a treatment stopped working without warning. Greer was sixteen and old enough to understand every clinical term, too young to change any of them. At the funeral, relatives praised her for explaining the disease calmly to younger cousins.

No one asked why she had memorized the pathology report.

Years later, Aurelia’s first assay slowed the same cellular process that accelerated Anna’s illness. Greer did not tell Rafe. Naming the connection would make failure personal, and she believed science demanded distance. Instead, the unspoken grief entered every late night and made stopping feel like abandoning her sister again.

Rafe arrived after Nolan left. He did not touch her.

“What do you need?” he asked.

It was different from asking what he could fix.

“A copy of every funding record. And space.”

“You can have both.”

He handed her a drive containing his private loan files. They showed he mortgaged Aldercrest shares and sold a family property to keep the lab open. Celeste used those transactions to accuse him of misusing corporate influence for his wife.

The board scheduled a removal vote.

Greer realized the plan attacked both of them through their deepest weaknesses: her belief that work excused everything and Rafe’s belief that love justified control.